Skip to main content
. 2021 Apr 27;11:9091. doi: 10.1038/s41598-021-88683-w

Figure 1.

Figure 1

HER2/HER3 expression and signaling in a panel of cancer cells. Cell lysates from a panel of HER2-overexpressing cancer cell lines were immunoblotted as indicated. For each subtype of cancer, cell lines without HER2 overexpression were also used as comparators. The three gels were run and transferred simultaneously and the immunoblots were performed simultaneously using the same primary and secondary immunoblotting solution preparations.